Jeremy Duffield
Chief Tech/Sci/R&D Officer at PRIME MEDICINE, INC.
Net worth: 7 M $ as of 2024-03-30
Profile
Jeremy Duffield is currently the Chief Scientific Officer at Prime Medicine, Inc. Prior to this, he worked as the Vice President of Business Development at Vertex Pharmaceuticals, Inc. from 2018 to 2021 and as Vice President at Biogen, Inc. from 2013 to 2019.
He is also a member of the American Society of Clinical Investigation.
Dr. Duffield holds a doctorate degree from both the University of Oxford and the University of Edinburgh.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PRIME MEDICINE, INC.
0.80% | 2024-02-20 | 965,001 ( 0.80% ) | 7 M $ | 2024-03-30 |
Jeremy Duffield active positions
| Companies | Position | Start |
|---|---|---|
| PRIME MEDICINE, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 |
Former positions of Jeremy Duffield
| Companies | Position | End |
|---|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 2020-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2019-08-31 |
| American Society of Clinical Investigation | Corporate Officer/Principal | - |
Training of Jeremy Duffield
| University of Oxford | Doctorate Degree |
| The University of Edinburgh | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| BIOGEN INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
| American Society of Clinical Investigation |
- Stock Market
- Insiders
- Jeremy Duffield
